| Date | Time | Source | Headline | Symbol | Company |
| 03/31/2009 | 4:05PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/31/2009 | 3:54PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/31/2009 | 11:35AM | Dow Jones News | UPDATE:FDA Sees Few Cardiovascular Events In Liraglutide Trials | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
| 03/31/2009 | 8:02AM | Business Wire | Eastbourne Capital Comments on Amylin Pharmaceuticals Lawsuit in Delaware & Recent Developments in Effort to Enjoin Company | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/31/2009 | 8:00AM | PR Newswire (US) | Exenatide Once Weekly Provided Superior Glucose Control With Weight Loss Compared to Sitagliptin or Pioglitazone in Head-to-Head | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/30/2009 | 4:07PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/30/2009 | 4:06PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/30/2009 | 10:13AM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/30/2009 | 9:49AM | Marketwired | WallStSense.com Initiates Free Ratings Report on PBCT, AMLN, ALKS and ATHR... Sign Up Now | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/30/2009 | 9:40AM | PR Newswire (US) | Beacon Equity Issues Technical Trade Alerts on Market Movers: AMLN, MPEL, ANAD, TBSI, NUVA, ITRI | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/30/2009 | 8:09AM | PR Newswire (US) | Amylin Pharmaceuticals Announces Slate of Directors for Annual Meeting of Stockholders | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/30/2009 | 8:00AM | Business Wire | Eastbourne Capital Management Comments on Delaware Lawsuit to Enjoin Amylin Pharmaceuticals “Poison Puts” | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/30/2009 | 7:57AM | Edgar (US Regulatory) | Proxy Statement - Contested Solicitations (preliminary) (PREC14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/27/2009 | 3:29PM | Dow Jones News | US EQUITIES WEEK AHEAD: Jobs Data, Auto Makers' Reports Due | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
| 03/26/2009 | 4:55PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/26/2009 | 8:00AM | PR Newswire (US) | Exenatide Clinical Data Analysis Shows No Increased Risk of Cardiovascular Events | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/19/2009 | 9:34AM | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/18/2009 | 4:37PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/13/2009 | 2:18PM | Dow Jones News | Study Downplays Risk Of Amylin's Byetta, But Concerns Remain | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
| 03/10/2009 | 4:15PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Cowen and Company Annual Health Care Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/09/2009 | 5:24PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/09/2009 | 4:53PM | Business Wire | Eastbourne Capital Management Sends Letter to Amylin Pharmaceuticals Board of Directors | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/09/2009 | 3:22PM | Dow Jones News | FDA Panel To Review Two Proposed Diabetes Drugs | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
| 03/06/2009 | 8:20PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/06/2009 | 8:20PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/06/2009 | 8:19PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/06/2009 | 8:19PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/06/2009 | 8:19PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/06/2009 | 8:19PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/06/2009 | 8:19PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |